1. Short title; table of contents (a) Short title This Act may be cited as the Nonalcoholic Steatohepatitis Care Act of 2020 or the NASH Care Act of 2020 . (b) Table of contents The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. National prevention program for diabetes, nonalcoholic fatty liver disease, and metabolic syndrome. Sec. 3. Grants for community-based patient education and provider training and outreach. Sec. 4. National Academies of Sciences study on education and policy needs for nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Sec. 5. National surveillance program for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Sec. 6. Recommendations for the prevention, screening, diagnosis, and treatment of interrelated conditions developed by multidisciplinary task force. Sec. 7. Renaming of NIH institute to reflect liver diseases and creation of division of liver diseases. 2. National prevention program for diabetes, nonalcoholic fatty liver disease, and metabolic syndrome Section 399V–3 of the Public Health Service Act (280g–14) is amended— (1) in subsection (a)— (A) by inserting or continue after establish ; (B) by striking national diabetes ; (C) by inserting , nonalcoholic fatty liver disease, and metabolic syndrome after high risk for diabetes ; and (D) by striking burden of diabetes and inserting such conditions ; (2) in subsection (b)— (A) by striking paragraph (1) (B) by redesignating paragraphs (2) through (4) as paragraphs (3) through (5); and (C) by inserting before paragraph (3) (as so redesignated) the following; (1) competitive grants to eligible entities for the purposes of identifying, developing, or disseminating best practices on the prevention, detection, and treatment of diabetes, nonalcoholic fatty liver disease, and metabolic syndrome; (2) competitive grants for eligible entities for the development of community-based prevention program model sites;